AKT1 and lung cancer: On H1299 and A549 lung cancer cells, EGCG inhibited the expression of Caspase-3, Bax, and Bcl-2 protein by inhibiting the activation of the PI3K/Akt signaling pathway in a dose-dependent manner [65].